NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 18, 2025 Bullish $2.18 X 0
Jul 17, 2025 $2.35 -2.54% $2.31 V 98.32% 1
Jul 17, 2025 $2.37 -1.59% $2.31 V 97.33% 1
Jul 17, 2025 $2.51 +4.15% $2.31 X 91.34% 0
Jul 16, 2025 $2.23 -1.68% $2.41 X 92.61% 0
Jul 16, 2025 $2.35 +3.52% $2.41 V 97.51% 1
Jul 15, 2025 $2.26 -2.62% $2.27 V 99.52% 5
Jul 15, 2025 $2.28 -1.64% $2.27 V 99.47% 4
Jul 15, 2025 $2.21 +6.76% $2.27 V 97.36% 0
Jul 14, 2025 $2.04 -1.62% $2.32 X 87.78% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE